VeriBlog

  • Turning Treatment Barriers into Drivers

    Turning Treatment Barriers into Drivers

    Improved compliance and adherence can lead to better health outcomes for patients and brand growth for drug manufacturers, but convincing patients to accept treatment is a well-recognized challenge.

  • The Subtle Ways that Words Influence Us

    The Subtle Ways that Words Influence Us

    [vc_row][vc_column][vc_column_text]Words matter—that’s why we do the work that we do at Verilogue. We all probably agree that having clear and effective communication is important, but even more than that, the very words we choose can subtly impact those with whom we’re speaking. While most physicians try to provide succinct and easy-to-understand instructions for their patients,…

  • Introducing VeriQual: Q&A with Stacy Hartung

    Introducing VeriQual: Q&A with Stacy Hartung

    [vc_row][vc_column][vc_column_text]You might know Verilogue as an “ethnographic market research company” or a “dialogue research company” but did you know we also specialize in other qualitative research methods? Since 2012, Verilogue has conducted hundreds of non-dialogue qualitative research studies and this year we have committed to allocating even more resources to grow these capabilities so we…

  • Verilogue Supports #Equalpayday

    Verilogue Supports #Equalpayday

    Verilogue Supports Equalpayday in 2018.

  • Why Do We Need Linguists?

    Why Do We Need Linguists?

    [vc_row][vc_column][vc_column_text]Imagine the preparation for an event like, let’s say, the Super Bowl. Coaches, players, trainers, and everyone else involved work constantly, together and alone, to be at peak performance when the big game rolls around. Now, imagine if, one day at practice, the coach just asked the players how they felt about their plays instead…

  • Two Reasons Why Drug Names Can Be A Challenge, Linguistically Speaking

    Two Reasons Why Drug Names Can Be A Challenge, Linguistically Speaking

    [vc_row][vc_column][vc_column_text]When I work on pipeline products, I always find the moment when drug names are announced incredibly fascinating, not just because it feels like the launch of a product’s identity in a sense, but also because the nuances of the name matter, maybe more than we realize. In the in-office dialogues, I hear the tentative…

  • The Top 3 Benefits of Message Optimization in Pharma

    The Top 3 Benefits of Message Optimization in Pharma

    [vc_row][vc_column][vc_column_text]In 2016, Pharmaceutical companies spent over 5.7 billion dollars globally in direct-to-consumer marketing. This is a 9% bump over 2015’s expenditures, a large increase for such a mature industry. With the growth of digital interconnectivity though, is this surprising? Tracking ROI and campaign performance is easier than ever, and budget allocations have been as accurate…

  • Ling 101: Resonating with your Audience

    Ling 101: Resonating with your Audience

    [vc_row][vc_column][vc_column_text]Hello and welcome back for the last installment of our Ling 101 mini-series! In this video, we discuss Metonymy and Synecdoche. Sound intimidating? Well fear not, as you have the dialogue experts to break it down for you, and show you how these concepts can help you resonate with your target audience.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_video link=”https://videopress.com/v/WiHrSuZp” align=”center”][/vc_column][/vc_row][vc_row css=”.vc_custom_1602759349655{border-bottom-width:…

  • 6 Steps to Harness Account-Based Marketing within Pharma

    6 Steps to Harness Account-Based Marketing within Pharma

    [vc_row css=”.vc_custom_1602759656162{border-bottom-width: 1px !important;border-bottom-color: #000000 !important;border-bottom-style: solid !important;}”][vc_column][vc_column_text]Marketing to the Pharma Sector can be quite challenging in today’s environment. Unlike normal B2B structures, these huge targets are comprised of some of the largest most profitable brands in the world, operating in arguably the most regulated sector imaginable. If this is not intimidating enough, some of…

  • Blogger Spotlight: ONC’s Response to ASCO 2017

    Blogger Spotlight: ONC’s Response to ASCO 2017

    [vc_row][vc_column][vc_column_text]Even though ASCO 2017 wrapped up over a month ago, we are still pretty curious and interested in what’s to come from the oncology community. We’re especially excited to hear what real attendees have to say about their experiences. Our curiosity sparked us to reach out to one of our Oncologists who went to ASCO…